论文部分内容阅读
目的观察吉西他滨、亚叶酸钙、氟尿嘧啶联合治疗晚期原发性肝癌的临床效果。方法选取近年来我院就诊的晚期原发性肝癌患者26例患者作为研究对象。全部患者采用吉西他滨、亚叶酸钙、氟尿嘧啶联合进行治疗;对比分析患者治疗效果及用药安全情况。结果经过3个疗程治疗后,26例患者中有23例患者症状均得到明显改善;Kamofsky评分得到不同程度的升高。结论采取吉西他滨、亚叶酸钙、氟尿嘧啶联合治疗晚期原发性肝癌,效果较好,不良反应轻微,对于改善患者症状有重要意义。
Objective To observe the clinical effects of gemcitabine, calcium folinate, and 5-fluorouracil combined with advanced primary liver cancer. Methods Twenty-six patients with advanced primary liver cancer who were treated in our hospital in recent years were selected as study subjects. All patients were treated with gemcitabine, calcium folinate, and fluorouracil; patients were compared for efficacy and safety. Results After 3 courses of treatment, symptoms in 23 of the 26 patients were significantly improved; the Kamofsky score increased to varying degrees. Conclusion The combination of gemcitabine, calcium folinate, and 5-fluorouracil in the treatment of advanced primary liver cancer has good efficacy and mild adverse reactions. It is of great significance to improve the symptoms of patients.